Lunai Bioworks Inc.

LNAI | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.41

+$0.11 (+4.78%)

Sep 22, 2026, 11:09 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $10.43M

Enterprise Value $8.68M

Beta 0.34

Average Volume 876.86K

Shares Outstanding (Diluted) 3.12M

Shares Change YoY 52.47%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US29350E3027

Price Performance

Price Change 1M 6.5%

Price Change 3M -46.5%

Price Change 6M -28.4%

Price Change YTD -70.4%

Price Change 1Y -79.8%

Price Change 3Y -77.7%

Price Change 5Y -77.7%

1M CAGR (ann.) -4.6%

1Y CAGR (ann.) -82.3%

5Y CAGR (ann.) N/A

All-Time CAGR -86.0%

Valuation

PE Ratio -0.04

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.00

PS Ratio 497.94

Forward PS N/A

PB Ratio -1.09

P/FCF Ratio -1.98

P/Adj. FCF Ratio -1.65

P/OCF Ratio -1.37

EV/Sales 414.67

EV/EBIT -0.88

EV/EBITDA -0.89

EV/FCF -1.65

Earnings Yield -2663.0%

FCF Yield -50.4%

Adj. FCF Yield -60.8%

Financial Health

Net Cash $1.88M

Total Debt $1.41M

Cash & Short-Term Investments $3.16M

Total Assets $9.86M

Current Ratio 0.19

Quick Ratio 0.19

Debt / Equity Ratio -0.15

Debt / EBITDA -0.14

Debt / FCF -0.27

OCF / Debt -3.73

Interest Coverage -16.23

Altman Z-Score -77.56

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin -360.7%

Operating Profit Margin -46992.0%

EBITDA Margin -609212.4%

Net Profit Margin -612568.1%

FCF Margin -25114.9%

Adj. FCF Margin -30267.8%

SBC / Revenue 6575.0%

SBC Impact (per share) -20.5%

Returns

Return on Assets -1301.0%

Return on Equity 892.5%

Return on Invested Capital 120.9%

Return on Capital Employed 104.5%

Return on Tangible Assets -3395.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -20.5%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y 19.2%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Sep 27, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-5.26M

Free Cash Flow $-5.26M

Adj. Free Cash Flow $-6.34M

FCF Per Share -$1.68

OCF Per Share -$1.68

OCF/S Ratio -25108.9%

Income Statement

Revenue $20.94K

Gross Profit $-75.54K

Operating Income $-9.84M

EBITDA $-9.74M

Net Income $-128.28M

EPS (Diluted) -$61.25

Revenue / Employee $722.14

Profit / Employee $-4.42M

Employees 29